4
Changes in Ownership
DiaMedica Therapeutics Inc. Filed Acc 0001235802-24-000053
Options or other derivatives
- Chief Business Officer acquired 130,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wambeke David J. Chief Business Officer | 2024-06-01 | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | D | ||
Loading xslF345X05/primary_doc.xml…